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http://dx.doi.org/10.1016/j.pedneo.2Background: Neonatal sepsis contributes to great mortality and morbidity among very-low-
birth-weight (VLBW) infants. Prevalence and pathogen distribution of sepsis in the neonatal
intensive care units (NICUs) vary with time and geographic location. Such information serves
as a guide for selection of empirical antibiotics coverage.
Methods: This is a case series study performed by retrospective chart review of VLBW infants
(birth body weight, BBW, <1500 g) in a medical center during a 5-year period from January
2005 to December 2009. Episodes of positive blood cultures, pathogen distribution and related
clinical manifestations were described.
Results: A total of 158 episodes of sepsis were identified from 1042 VLBW infants. Sepsis rate
was 152 per 1000 live births. The vast majority of infections (60.7%) were caused by Gram-
positive organisms [G(þ)], and overall Coagulase-negative staphylococci (CoNS ) (52.5%) were
the most common pathogen identified. Prevalence for early-onset sepsis (EOS) was 1% and for
late-onset sepsis (LOS) was 14.2%. Infants with EOS had a much higher case fatality rate than
LOS (40% vs. 4.7%). Escherichia coli (40%) were the leading pathogen of EOS while CoNS (54.7%)
was the leading pathogens of LOS. Overall, apnea and/or bradycardia and/or cyanosis (65.8%),
poor activity (48.7%), and increased respiratory effort (43.0%) were the most common present-
ing features of sepsis.Neonatology, Department of Pediatrics, Chang Gung Children’s Hospital, No. 5, Fu-Shing Street,
org.tw (R. Lien).
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Sepsis in very-low-birth-weight infants 229Conclusion: Unlike term infants, Gram-negative organism and E coli were the leading pathogen
of EOS among VLBW infants. Judicious and timely use of antibiotic therapy is crucial in the care
of VLBW infants.
Copyright ª 2012, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Recent advances in neonatal care have successfully
improved survival rate and reduced complications in
premature infants. However, sepsis remains a significant
and frequent cause of mortality and morbidity in very-low-
birth-weight (VLBW) infants.1,2 Early recognition of clinical
signs implying significant infection and an appropriate
choice of empirical antibiotics are vital for successful
management of sepsis. Rationale on choices of empirical
antibiotics should be based on epidemiologic knowledge of
frequent pathogens and their drug sensitivity. While risk
factors for sepsis in VLBW infants may differ from those
found in term infants, also true is the fact that causative
pathogens for neonatal sepsis vary with time and
geographic distribution.
Current available studies have all been focused on sepsis
in all neonatal intensive care unit (NICU) patients, or only
on early onset sepsis (EOS) or late onset sepsis (LOS) of
VLBW infants.1,2 The aim of this study was to describe
current epidemiologic, microbiologic, and clinical charac-
teristics of both EOS and LOS among VLBW infants in
a medical center in northern Taiwan.2. Methods
This is a retrospective case study conducted in the NICUs
of Chang Gung Memorial Hospital (CGMH), Lin Kou, by
analyzing the NICU database and reviewing medical
records. All preterm infants admitted to these NICUs
between January 2005 to December 2009 with birth body
weight, (BBW) < 1500 g, who also had a diagnosis of
neonatal sepsis were enrolled in this study. Their medical
records were reviewed and relevant clinical features
including presenting symptoms, laboratory findings such
as culture results, use of antibiotics, possible risk
factors, especially use of indwelling catheters, ventila-
tors, and parenteral nutrition were recorded and
analyzed.
Sepsis was defined by a positive blood culture and clin-
ical symptoms. EOS was defined as sepsis within the first
3 days of life while LOS was defined as any episodes
occurring after 3 days of life.2 Blood cultures positive for
organisms generally considered as contaminants, including
corynebacterium, propionibacterium, penicillium, and
diphtheroids, were excluded.1 For patients with multiple
episodes of sepsis, only those with the same pathogen
identified after a 10-day course of appropriate antibiotic
therapy or a different organism identified from an in vitro
susceptible culture were considered as different episodes.1
For Coagulase-negative staphylococci (CoNS ), those withtwo positive cultures of blood specimens drawn within
2 days or one positive culture and a serum C-reactive
protein (CRP) level greater than 1 mg/dL within 2 days were
considered as definite cases; those with one positive
culture and treated with an antistaphylococcal drug to
which the organism was susceptible for at least 5 days were
considered as possible cases.1 Contamination was defined
as one positive culture without an elevated CRP or antibi-
otic therapy. Definite and possible cases were included in
this study.
Central venous catheter (CVC) and endotracheal tube
placed before the onset of sepsis and in place at the time of
positive blood culture were defined as CVC at sepsis and
ventilator at sepsis, respectively. Total parenteral nutrition
(TPN) used before and during the time of positive blood
culture was defined as TPN at sepsis. For clinical symptoms,
apnea, and/or bradycardia, and/or cyanosis were included
when the episodes were new in onset, more frequent, or
more severe than previously observed. Fever and hypo-
thermia were defined as a core body temperature of 38C
or 36.5C, respectively. Hyperglycemia was defined as
blood glucose of 140 mg/dL.2 New onset of hypotension
with use and increasing dose of inotropes were defined as
hypotension during sepsis. Thrombocytopenia was defined
as a platelet count of <150,000/mm3. Increased respiratory
effort was defined as increased fraction of inspired oxygen
(FiO2), positive inspiratory pressure, or end expiratory
pressure at onset of sepsis.
Statistical analysis was performed using the SPSS soft-
ware version 15.0 (SPSS Inc.,Chicago, IL, USA).
Categorical data were analyzed with the standard chi
square test. Continuous data were analyzed with indepen-
dent t test and analysis of variance (ANOVA) was applied for
intergroup comparisons. Statistical significance was defined
as p  0.05.3. Results3.1. Prevalence
Between January 2005 and December 2009, there were
a total of 1042 preterm infants with BBW of less than 1500 g
admitted to our NICUs. A total of 134 infants had one or
more episodes of blood culture-proven sepsis. After
excluding eight infants with 10 episodes of blood culture
positive for an organism considered as a contaminant, 126
(12.9%) infants with 158 episodes of sepsis were included in
our study. The sepsis rate was 15.2%. Among these infants,
99 infants had a single episode of sepsis (78.6%), 20 infants
(20.9%) had two episodes, and seven infants (5.6%) had
three episodes of sepsis.
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infants (114/126; 90.5%) with a mean gestational age (GA)
of 28  3 weeks and a mean BBW of 994  249 g. Sixty
infants (47.6%) were male and 66 were female. Eighty
(63.5%) infants were born by Cesarean section (C/S).3.2. Distribution of pathogens
The vast majority of sepsis was caused by Gram-positive
[G(þ)] organisms (96/158; 60.7%). Among G(þ) organisms,
CoNS (83/96; 86.5%) was the most common identified
pathogen, followed by Enterococcus fecalis (5/96; 5.2%)
and methicillin-resistant staphylococcus aureus (MRSA; 5/
96; 5.2%). This is shown in Table 1. Gram-negative organ-
isms [G(e)] accounted for 35.4% (56/158) of sepsis, with
Klebsiella pneumoniae (19/56; 33.9%) as the most common
pathogen. Escherichia coli (16/56; 28.6%) ranked second
and Acineto baumannii (7/56; 12.5%) ranked third.
Four episodes of sepsis were caused by extended spec-
trum b-lactamase (ESBL)-producing organisms, including
two K pneumoniae, one Klebsiella oxytoca, and one E coli.
The overall incidence of sepsis caused by ESBL-producing
strain was 2.5 % (4/158).
Fungal infection caused by Candidia albicans and
C parapsilosis accounted for 3.8% of sepsis.
Among all pathogens, CoNS (83/158; 52.5%) was the
most predominant pathogen in causing neonatal sepsis,Table 1 Distribution of pathogens, day of onset of sepsis and a
Gung Memorial Hospital, 2005e2009.
Pathogens Number with
sepsis, n (%)
G(þ) 96 (60. 7)
CoNS 83 (52.5)
MRSA 5 (3.2)
Enterococcus fecalis 5 (3.2)
MSSA 1 (0.6)
Viridans streptococcus 1 (0.6)
Pneumococcus 1 (0.6)
G(e) 56 (35.4)
Klebsiella pneumoniae 19 (12.0)
E coli 16 (10.1)
Acineto baumannii 7 (4.4)
Entero aerogenes 3 (1.9)
Entero cloacae 3 (1.9)
Klebsiella oxytoca 2 (1.3)
ESBL-KO 2 (1.3)
ESBL-KP 2 (1.3)
ESBL-E coli 1 (0.6)
Serratia marcescens 1 (0.6)
Pseudomonas 1 (0.6)
Fungi 6 (3.8)
Candidia albicans 4 (2.5)
Candidia parapsilosis 2 (1.3)
Overall 158 (100.0)
CoNS Z coagulase-negative staphylococcus; ESBL-KO Z extende
KP Z extended spectrum b-lactamase producing Klebsiella pneumon
methicillin-sensitive staphylococcus aureus.followed by K pneumonia (19/158; 12.0%) and E coli
(16/158; 10.1%).
3.3. Prevalence and pathogen distribution of EOS
and LOS
EOS occurred in 10 VLBW infants with 10 episodes of sepsis
and accounted for 6.3% of all sepsis episodes (10/158). This
is shown in Table 2. Prevalence of EOS in this study pop-
ulation was 1%. The median and mean ages of onset of EOS
were 1 day and 1.1  0.3 days, respectively. E coli (4/10;
40%), K pneumoniae (2/10; 20%), and CoNS (2/10; 20%)
were the common organisms identified. No EOS was caused
by group B streptococci (GBS). There was one (1/10) EOS
caused by fungus.
LOS accounted for 93.7% of sepsis episodes among our
VLBW infants. Prevalence of LOS was 14.2%. The median
and mean ages of LOS were 25 days and 34.6  2.5 days,
respectively. Pathogens for LOS were 62.8% (93/148) G(þ)
bacteria, 33.8% (50/148) G(e) bacteria, and 3.5% (5/148)
fungus. Among LOS, CoNS (81/148; 54.7%) was the most
common pathogen, followed by K pneumonia (17/148;
11.5%) and E coli (12/148; 8.1%).
3.4. Mortality
The case fatality rate of sepsis among VLBW infants was
7.0% (11/158). Infants with EOS had a much higher fatalityssociated mortality of 158 episodes neonatal sepsis at Chang
Sepsis-related
mortality, n (%)
Onset of sepsis (d)
Median Mean  SD
2 (2.1) 25 34.6  3.2
2 (2.4)
0
0
0
0
0
7 (12.5) 25.5 35.4  4.2
0
3 (18.6)
2 (28.6)
0
0
0
0
0
1 (100.0)
0
1 (100.0)
2 (33.3) 17.5 28.5  11.1
1 (25)
1 (50)
11 (7.0) 25.0 36.6  2.5
d spectrum b-lactamase producing Klebsiella oxytoca; ESBL-
iae; MRSA = methicillin-resistance staphylococcus aureus; MSSA =
Table 2 Distribution of pathogens and associated mortality for EOS and LOS.
Pathogens EOS, n (%) LOS, n (%)
Episodes Mortality Episodes Mortality
G(þ) 3 (30.0) 0 93 (62.8) 2 (2.2)
CoNS 2 (20.0) 0 81 (54.7) 2 (2.6)
MRSA 0 0 5 (3.4) 0
Enterococcus fecalis 0 0 5 (3.4) 0
MSSA 0 0 1 (0.7) 0
Viridans streptococcus 1 (10.0) 0 0 0
Pneumococcus 0 0 1 (0.7) 0
G() 6 (60) 3 (50.0) 50 (33. 8) 5 (10.0)
K pneumoniae 2 (20) 0 17 (11.5) 0
E coli 4 (40) 3 (75.0) 12 (8.1) 0
Acineto baumannii 0 0 7 (4.7) 2 (28.6)
Entero aerogenes 0 0 3 (2.0) 0
Entero cloacae 0 0 3 (2.0) 0
Klebsiella oxytoca 0 0 2 (1.4) 0
ESBL-KO 0 0 1 (0.7) 0
ESBL-KP 0 0 2 (1.4) 1 (50.0)
ESBL E coli 0 0 1 (0.7) 0
Serratia marcescens 0 0 1 (0.7) 0
Pseudomonas 0 0 1 (0.7) 1 (100.0)
Fungi 1 (10.0) 1 (10.00) 5 (3.4) 1 (20.0)
Candidia albicans 1 (100) 1 (100.0) 3 (2.0) 0
Candidia parapsilosis 0 0 2 (1.4) 1 (50.0)
Overall 10 (6.3) 4 (40.0)* 148 (93.7) 7 (4.7)*
*p < 0.05.
CoNS Z coagulase-negative staphylococcus; ESBL-KO Z extended spectrum b-lactamase producing Klebsiella oxytoca; ESBL-
KP Z extended spectrum b-lactamase producing Klebsiella pneumoniae; MRSA Z methicillin-resistance staphylococcus aureus;
MSSA Z methicillin-sensitive staphylococcus aureus.
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was the predominant pathogen among fatal EOS, while
A baumannii and CoNS were the top two pathogens to
cause death in LOS. Mortality rates are shown in Tables 1
and 2.
Overall, sepsis caused by fungus (2/6; 33.3%) and G(e)
bacteria (7/56; 12.5%) were associated with higher
mortality rate than G(þ) bacteria (2/96; 2.1%; p < 0.01).
Seventy-two percent of mortality cases died within 3 days
of diagnosis of sepsis. All G(e) sepsis cases died within 3
days, with a median age of 1 day. Instead, those infants
with sepsis caused by G(þ) organisms or fungus died with
median ages of 9 days and 6 days, respectively.3.5. Drug susceptibility of the pathogens
Beta-lactam antibiotics in combination with an amino-
glycoside were the most common empirical regimen used.
Vancomycin (92/158; 58.3%), oxacillin (51/158; 32.3%),
ampicillin (15/158; 9.5%), and gentamicin (64/158; 40.5%)
were common antibiotics used. A third-generation cepha-
losporin was used instead of gentamicin for critically ill
infants, with cefotaxime (76/158; 48.1%) being the most
common regimen.
There were 17 episodes of E coli sepsis with 11.8% (2/17)
ampicillin-resistant rate and 5.9% (1/17) ESBL-strain. Allthe CoNS and 83.3% of staphylococcus aureus (SA) isolates
were resistant to oxacillin.
3.6. Clinical signs and symptoms
Apnea, and/or bradycardia, and/or cyanosis (104/158;
65.8%) were the most common presenting features of
sepsis, followed by poor activity (77/158; 48.7%) and
increased respiratory effort (68/158; 43.0%). In addition,
infection caused by G(e) bacteria or fungus usually pre-
sented with more severe clinical symptoms, including
apnea, and/or bradycardia, and/or cyanosis (p Z 0.01),
poor activity (p Z 0.016), and shock (p < 0.001) when
compared with G(þ) sepsis cases (Tables 3 and 4).
3.7. Laboratory parameters
Elevated CRP (84.2 %) was the most common laboratory
finding during sepsis (Tables 3 and 5). Thrombocytopenia
(47.5%) and hyperglycemia (37.3%) were also common.
Leukocytosis (5.1%) and neutropenia (12.7%) were
uncommon. When compared with patients with G(þ) sepsis,
those with G(e) or fungal infection had a significantly higher
incidence of neutropenia, thrombocytopenia and coagulop-
athy (p< 0.001). Patients with EOS had higher percentage of
coagulopathy, neutropenia and immature-to-total neutro-
phil count (I/T ratio) > 0.2 then LOS (p < 0.005).
Table 3 Clinical signs, symptoms and laboratory data presented by different pathogens during sepsis.
Laboratory data Pathogens p value
Gram(þ) Gram() Fungi Overall
n (%) n (%) n (%) n (%)
Elevated CRP 74 (77.1) 53 (94.6) 6 (100.0) 133 (84.2) 0.009*
Thrombocytopenia 30 (31.3) 40 (71.4) 5 (83.3) 75 (47.5) <0.001y
Hyperglycemia 27 (28.1) 31 (55.4) 1 (16. 7) 59 (37.3) 0.015*
Coagulopathy 2 (2.1) 21 (37.5) 1 (16. 7) 24 (15.2) <0.001y
Neutropenia 4 (4.2) 13 (23.2) 3 (50) 20 (12.7) <0.001y
I/T > 0.2 3 (3.1) 9 (16.1) 1 (16. 7) 13 (8.2) 0.015*
Leukocytosis 3 (3.1) 5 (8.9) 0 (0.0) 8 (5.1) 0.250
Symptoms
Apnea and/or bradycardia
and/or cyanosis
55 (57.3) 43 (76.8) 6 (100.0) 104 (65.8) 0.010*
Poor activity 38 (39.6) 35 (62.5) 4 (66. 7) 77 (48.7) 0.016*
Increased respiratory effort 34 (35.4) 29 (43.9) 5 (83.3) 68 (43.0) 0.018*
Tachycardia 30 (31.3) 28 (50.0) 0 (0.0) 58 (36.7) 0.011*
Fever 27 (28.1) 14 (25.0) 0 (0.0) 41 (26.0) 0.306
Hypotension 3 (3.2) 16 (28.6) 1 (16. 7) 20 (12.7) <0.001y
Hypothermia 5 (5.2) 5 (8.9) 0 (0.0) 10 (6.3) 0.536
*p < 0.05.
yp < 0.001.
Number of Gram(þ) organisms Z 96; number of Gram(e) organisms Z 56; number of fungi Z 6.
CRP Z C-reactive protein; I/T ratio Z immature-to-total neutrophil count ratio.
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CVC was found in 79.8% (126/158) of sepsis, with mean and
median duration of 15  1 days and 14 days, respectivelyTable 4 Clinical signs and laboratory data of EOS and LOS.
Laboratory data EOS LOS p value
n (%) n (%)
Elevated CRP 7 (70.0) 126 (86.9) 0.196
Thrombocytopenia 5 (50.0) 70 (47.3) 0.562
Hyperglycemia 3 (30.0) 56 (37.8) 0.652
Coagulopathy 7 (70.0) 17 (11.5) <0.001*
Neutropenia 5 (50.0) 15 (10.1) 0.003y
I/T > 0.2 3 (30.0) 10 (6.7) 0.038y
Leukocytosis 1 (10.0) 7 (4.7) 0.415
Symptoms
Apnea and/or bradycardia
and/or cyanosis
6 (60.0) 98 (66.2) 0.464
Poor activity 5 (50.0) 72 (48.7) 0.595
Increased respiratory
effort
5 (50.0) 63 (42.6) 0.443
Tachycardia 4 (40.0) 54 (46.5) 0.535
Fever 1 (10.0) 40 (27.0) 0.214
Hypotension 7 (70.0) 13 (8.8) <0.001*
Hypothermia 1 (10.0) 9 (6.1) 0.490
*p < 0.001.
yp < 0.05.
BBWZ birth body weight; CRPZ C-reactive protein; CVCZcen-
tral venous catheter;GAZ gestational age; I/TratioZ immature-
to-total neutrophil count ratio; PPROM Z preterm premature
rupture of membrane; TPNZ total parenteral nutrition.(Table 5). Mechanical ventilator was used in 65.2% (103/
158) episodes, with mean and median duration of
11  1days and 3 days, respectively. In addition, TPN was
used among 102 (64. 6%) episodes of sepsis, with mean and
median duration of 20  2days and 17 days, respectively.
There was no statistical significant difference in the
demographic distribution or risk factors such as antenatal
steroid, antenatal antibiotics, duration of mechanical
ventilation, TPN, and CVC insertion, in patients who
developed sepsis by G(þ) pathogens, G(e) pathogens, or
fungus.
Patients with EOS had a higher percentage of preterm
premature ruptured of membrane (PPROM), chorioamnio-
nitis, antenatal steroid, and antibiotics usage compared
with LOS cases, but didn’t reach statistical significance. By
contrast, LOS had more TPN usage and CVC than EOS (p
<0.001).4. Discussion
According to previous studies in Taiwan, the prevalence of
neonatal sepsis ranged from 3.0% to 9.3%.3e6 However,
none of these reports were focused on VLBW populations.
VLBW infants are at the greatest risk of infection because
of compromised immunity, prolonged hyperalimentation,
CVC catherization and mechanical ventilation. Our study
provides the most updated data about this high-risk group.
The sepsis rate among VLBW infants was 15.2% in our study,
comparable to what was reported in the National Institute
of Child Health and Human Development (NICHD) study
(11.0%e32.0%).1
In our study, the vast majority of sepsis was LOS (93.7%),
and CoNS (52.5%) was the most common causative
Table 5 Possible risk factors of different pathogens in causing neonatal sepsis.
Risk factors Gram(+) Gram(e) Fungi Overall p value
n (%) n (%) n (%) n (%)
GA (wk) 27.7  2.6 28.2  2.7 25.4  1.8 27.8  2.7 0.070
BBW (g) 997.7  250.0 1010.3  242.9 810.  279.5 994.6  249.4 0.234
Gender (male) 38 (39.6) 21 (37.5) 1 (16.7) 60 (47.6) 0.440
Vaginal delivery 28 (29.2) 14 (25.0) 4 (66.7) 46 (36.5) 0.105
PPROM 26 (27.1) 15 (26.8) 2 (33.3) 43 (34.1) 0.960
Chorioamnionitis 1 (1.0) 2 (3.6) 1 (16.7) 4 (2.5) 0.056
Antenatal antibiotics 21 (21.9) 14 (25.0) 3 (50.0) 38 (24.1) 0.290
Antenatal steroid 50 (52.1) 30 (56.6) 2 (40.0) 82 (51.9) 0.475
TPN at sepsis 66 (68.8) 32 (57.1) 4 (66.7) 102 (64.6) 0.203
Mean duration (d) 20.8  2.1 17.9  3.9 22.5  14.5 19.81  1.9 0.740
CVC at sepsis 79 (82.3) 43 (76.8) 4 (66.7) 126 (79.8) 0.443
Mean duration (d) 16.6  1.2 14.0  1.7 6.8  2.5 15.3  1 0.101
Ventilator at sepsis 64 (66. 7) 36 (64.3) 3 (50.0) 103 (65.2) 0.659
Mean duration (d) 12.5  1.6 10.2  2.3 6.4  3.5 11.4  1.3 0.515
Total number of patients Z 126; number of Gram(þ) pathogens Z 96; number of Gram(e) pathogens Z 56; number of fungi Z 6.
BBWZ birth body weight; CVCZ central venous catheter; GAZ gestational age; PPROMZ preterm premature rupture of membrane;
TPNZ total parenteral nutrition.
Sepsis in very-low-birth-weight infants 233organism. These observations were also noted in other
studies in United States and Israel.1,2,7e10 The sepsis-
related mortality rate of CoNS was 2.4% in our study and
was compatible with those in other studies (3%e9.5%).1,2,5,9
All CoNS in our study was resistant to the routinely used
empirical antibiotics, and vancomycin was used as empir-
ical antibiotics in 58.3% of cases.5,11 Karlowicz stated that
such widespread use of vancomycin would result in emer-
gence of vancomycin-resistant strains.12 There was also
report of successful treatment of methicillin-resistant CoNS
with first-generation cephalosporins instead of vancomy-
cin.11 Considering the low virulence of CoNS infections and
emergence of resistant strains, it is reasonable to use
ampicillin or oxacillin empirically for patients with fair
clinical status in suspicious of LOS.
Among G(e) pathogens, K pneumoniae and E coli were
the predominant strains in our study, which is consistent
with other literature.1,2,9 By contrast to other Taiwanese
studies with GBS as the most common pathogen,3e6 G(e)
pathogens and E coli were the leading cause of EOS among
VLBW infants in our study. Similar trend have been reported
in the United States, with E coli replacing GBS as the
leading cause of EOS in VLBW after the introduction of
intrapartum antibiotic prophylaxis (IAP) program.13e15
Since 90% of the infants in our study were inborn and IAP
had already implemented for most of our cases, this may
explain the high incidence of E coli in our study. The
widespread use of IAP has result in emergence of non-GBS
strains and antibiotic resistance.13 However, only 11.8% of
the isolates were ampicillin-resistant in our study. One
reason for such low resistance rate may contribute to
inadequate time for resistant strains to emerge as we
adopted use of IAP in recent years. Thus, it was safety for
us to use ampicillin and gentamicin as empirical antibiotics
for suspected EOS cases. Considering the high mortality
rate of EOS and emergence of highly virulent G(e) organ-
isms found in our study, third- generation cephalosporins
such as cefotaxime should replace gentamicin for sickinfants or suspicion of resistant strains. Further surveillance
tests to determine the emergence of G(e) EOS as well as
antibiotic resistance are warranted.
Fungal infection was rare in our study, with C albicans
the leading strain.1,16,17 The mortality rate was 33.3% in our
study, which was similar to that of NICHD study.1 Invasive
fungal infections were related to low birth weight, low GA,
prolonged use of third-generation cephalosporins, endo-
tracheal intubation and intravenous access.17 Thus, most
fungal infections contributed to LOS. In our study, C para-
psilosis had a higher mortality rate in compare with C
albicans. One reason is due to the relative small sample
size, which didn’t reach statistical significance, further-
more, C parapsilosis is difficult to eradicate, and this may
also contribute to the high mortality rate.18
Clinical signs and laboratory findings during sepsis were
non-specific. Apnea, and/or bradycardia, and/or cyanosis,
poor activity, and increased respiratory effort were the
most common clinical indicators of sepsis in our study. Wu
and colleagues5 also had similar findings. Despite clinical
symptoms, laboratory data were non-specific in deter-
mining sepsis. In our study, G(e) sepsis patients were found
to have higher incidence of thrombocytopenia, neutropenia
and I/T ratio > 0.2, which were consistent with the other
reports. Several endotoxin and lipopolysaccharides of G(e)
organisms, including E coli ELA and K pneumonia O antigen,
were responsible to such result.19e21
Prolonged use of CVC, mechanical ventilator, and TPN
are related to infection. According to Stoll’s study,1,2
mechanical ventilation with mean days of 23.7  0.5, CVC
with mean days of 16.4  0.4 and TPN with mean days of
33.1  0.5 were associated with increased risk of LOS,
which was comparable to our study. Thus, removal of CVC,
extubation and enteral feeding should be initiated as early
as possible. Although low BBW, low GA, prolonged CVC,
prolonged TPN, and PPROM were risk factors of G(e) LOS
sepsis among VLBW infants,22 our study did not find any
correlation. One reason is that there is no difference in GA
234 W.H. Lim et alamong EOS and LOS group in our study, as Samanta23 re-
ported prolonged TPN was the only independent risk factor
after elimination the effect of GA. For fungal infection,
statistical significance may not be reached due to small
sample size.
In summary, sepsis remains to be a serious threat to
VLBW infants. Clinicians should be vigilant to any subtle
signs of infection. Judicious and timely use of effective
antibiotic therapy is crucial in the care of VLBW infants.
Our result provides objective guidance in decision of
choosing empirical antibiotics in such situation.
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